MKS (NASDAQ:MKSI) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says

MKS (NASDAQ:MKSI) had its target price lifted by equities research analysts at JPMorgan Chase & Co. from $265.00 to $305.00 in a report issued on Thursday,Benzinga reports. The firm currently has an “overweight” rating on the scientific and technical instruments company’s stock. JPMorgan Chase & Co.‘s price target indicates a potential upside of 17.64% from the stock’s previous close.

A number of other research firms have also recently weighed in on MKSI. Bank of America raised their price target on MKS from $215.00 to $255.00 and gave the company a “buy” rating in a research note on Thursday, January 22nd. Weiss Ratings reissued a “hold (c)” rating on shares of MKS in a research report on Thursday, January 22nd. Zacks Research upgraded MKS from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 23rd. Benchmark increased their price target on shares of MKS from $135.00 to $180.00 and gave the company a “buy” rating in a research note on Friday, November 7th. Finally, KeyCorp reissued an “overweight” rating and set a $310.00 price objective on shares of MKS in a report on Wednesday. One analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $273.46.

MKS Stock Up 4.1%

Shares of MKS stock opened at $259.27 on Thursday. The company has a quick ratio of 1.81, a current ratio of 2.71 and a debt-to-equity ratio of 1.53. MKS has a 52-week low of $54.84 and a 52-week high of $269.91. The company has a market capitalization of $17.42 billion, a P/E ratio of 59.33, a P/E/G ratio of 1.71 and a beta of 1.95. The company has a 50 day moving average of $204.86 and a 200 day moving average of $155.92.

MKS (NASDAQ:MKSI) last announced its quarterly earnings data on Tuesday, February 17th. The scientific and technical instruments company reported $2.47 earnings per share for the quarter, missing analysts’ consensus estimates of $2.51 by ($0.04). The firm had revenue of $1.03 billion during the quarter, compared to analyst estimates of $1.02 billion. MKS had a net margin of 7.53% and a return on equity of 20.85%. MKS’s revenue for the quarter was up 10.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.15 earnings per share. MKS has set its Q1 2026 guidance at 1.720-2.280 EPS. As a group, research analysts forecast that MKS will post 6.94 EPS for the current fiscal year.

Insider Buying and Selling at MKS

In other news, Director Elizabeth Mora sold 300 shares of the business’s stock in a transaction that occurred on Tuesday, December 2nd. The stock was sold at an average price of $158.81, for a total value of $47,643.00. Following the transaction, the director owned 18,963 shares of the company’s stock, valued at approximately $3,011,514.03. The trade was a 1.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.57% of the company’s stock.

Hedge Funds Weigh In On MKS

Hedge funds and other institutional investors have recently bought and sold shares of the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in MKS by 3.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 267,421 shares of the scientific and technical instruments company’s stock worth $21,434,000 after buying an additional 9,170 shares during the period. CWM LLC boosted its stake in shares of MKS by 139.1% during the 2nd quarter. CWM LLC now owns 6,154 shares of the scientific and technical instruments company’s stock worth $611,000 after acquiring an additional 3,580 shares in the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in shares of MKS in the 2nd quarter worth approximately $527,000. Ethic Inc. grew its holdings in shares of MKS by 24.8% in the 2nd quarter. Ethic Inc. now owns 22,297 shares of the scientific and technical instruments company’s stock worth $2,234,000 after acquiring an additional 4,434 shares during the period. Finally, Brighton Jones LLC purchased a new position in MKS in the 2nd quarter valued at approximately $336,000. 99.79% of the stock is currently owned by hedge funds and other institutional investors.

Trending Headlines about MKS

Here are the key news stories impacting MKS this week:

• Positive Sentiment: Q4 revenue beat and segment strength — MKS reported $1.03B in Q4 revenue (+10% YoY) with Electronics & Packaging up ~19%, showing demand strength in key end markets that supports higher earnings power. MKS Inc. (MKSI) Reports $1.03B Q4 2025 Revenue
• Positive Sentiment: JPMorgan raised its price target to $305 and keeps an overweight rating — a bullish analyst move that likely boosted investor confidence and helped lift the stock. JPMorgan raises MKSI price target
• Positive Sentiment: Needham increased its target to $300 and maintains a buy rating — another bullish signal adding upward pressure. Needham raises MKSI price target
• Neutral Sentiment: Wells Fargo raised its target to $255 but kept an equal‑weight rating — a modestly constructive update, though its PT sits near the stock price and signals limited upside. Wells Fargo raises MKSI price target
• Neutral Sentiment: Full earnings call transcript is available for detail seekers — useful for judging management tone on orders, backlog and guidance. MKS Q4 2025 earnings call transcript
• Negative Sentiment: Small EPS miss — Q4 EPS $2.47 vs. consensus $2.51 (miss by $0.04). The slight miss tempered the rally and left some investors wanting a larger beat.
• Negative Sentiment: Mixed/contrarian analyst views: Goldman Sachs raised its price target (to $200) but maintains a sell rating, signaling that some firms still see meaningful downside — this contributes to mixed market reaction. Goldman raises PT but keeps sell rating
• Negative Sentiment: Investor disappointment / short‑term selling pressure — stories about the stock gapping down and falling after the print reflect that some traders sought a larger beat, creating intraday swings despite underlying revenue strength. MKS shares gap down following weak earnings MKS stock falls; investors wanted larger beat

MKS Company Profile

MKS Instruments, Inc (NASDAQ: MKSI) designs, manufactures and markets technology solutions that enable advanced processes in a variety of high‐technology and industrial markets. The company’s core offerings include vacuum and gas delivery systems, pressure and flow measurement instruments, optical metrology tools, photonics subsystems and critical components for manufacturing processes. These products support the precise control and monitoring needs of semiconductor, industrial manufacturing, life and health sciences, and research applications.

The company’s product portfolio features mass flow controllers, pressure transducers, vacuum gauges, gas purity monitors, laser-based metrology systems and photonic devices such as lasers and detectors.